Syntek Capital

Syntek Capital was a private equity and venture capital firm that focused on early-stage and growth-capital investments in the technology, media, and life sciences sectors. Founded in 2000 by Stefan Roever, the firm operated with a 'venture building' philosophy, providing not only capital but also strategic and operational support to its portfolio companies. In the biotechnology arena, Syntek Capital was instrumental in the early development of several high-profile companies, including vaccine developer Intercell and DNA sequencing innovator Genia Technologies. The firm maintained a global presence with offices in Munich, London, and New York, targeting disruptive technologies with high growth potential. Although the firm is no longer actively making new investments, its legacy includes several successful exits and mergers within the global healthcare and technology markets.